Norwalk, CT - October 3, 2024 – LifeSpan Vision Ventures, an investment firm specializing in the aging and longevity space, today announced participation in Integrated Biosciences’ oversubscribed Series Seed round. Lifespan Vision Ventures joins Sutter Hill Ventures, the lead investor, alongside Civilization Ventures, Overlap Holdings, SH Fund (Sabrina Hahn), Michael Stoppelman, and Vijay Pandurangan and existing investors Illumina Ventures, Root Ventures, Mission BioCapital, Conscience VC, Reinforced Ventures, and Polymath Capital.
Integrated Biosciences is pioneering the use of synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases. The company has previously advanced groundbreaking approaches to AI-driven and anti-aging small molecule discovery, as described in the company’s previous Nature, Nature Aging, and Cell Systems publications. Integrated Biosciences is currently developing a portfolio of preclinical-stage assets that are drug candidates for multiple age-related diseases.
Harry Robb, Analyst at LifeSpan Vision Ventures, said, “LifeSpan Vision Ventures is dedicated to supporting innovative companies focused on addressing the underlying causes of age-related diseases. Integrated Biosciences’ proprietary synthetic biology platform leverages optogenetics to activate cellular stress responses, enabling the discovery of targeted therapies for stressed cells and accelerating the identification of drug targets. We are enthusiastic about supporting Integrated Biosciences as they pioneer scalable solutions in the integrated stress response (ISR) drug discovery field, among others, with a focus on developing small molecule therapeutics that promote healthy aging.”
Felix Wong, Ph.D. co-founder of Integrated Biosciences, stated, “We started Integrated Biosciences to make real progress toward achieving healthier human aging. This fundraise, comprised of a world-class syndicate of investors, will bring us closer to our ambitious goal by enabling us to accelerate our preclinical drug development and advance our science and commercialization efforts. We are thrilled to welcome LifeSpan Vision Ventures to Integrated and look forward to continuing our exciting journey together.”
About Integrated Biosciences
Integrated Biosciences is a biotechnology company pioneering novel approaches that combine synthetic biology and AI-driven small-molecule drug discovery to produce next-generation therapeutics targeting age-related diseases.
For more information, visit: www.integratedbiosciences.com.
About LifeSpan Vision Ventures
LifeSpan Vision Ventures is a forward-thinking venture capital firm specializing in investments within the aging and longevity space. Our mission is to support and accelerate the development of innovative therapies that extend healthspan, improve the quality of life for individuals as they age, and address age-related challenges. Through strategic partnerships and investments, we aim to shape a future where aging is met with vitality, resilience, and endless possibilities.
Contact: Harry Robb, Analyst: harry.robb@lifespanvision.com
Comments